Phase 3 readouts expected in 2026

Every Phase 3 and Phase 2/3 study on a drug AssetMemo covers whose estimated primary completion date falls in 2026 and is still ahead, by month. The primary completion date is the sponsor's estimate of when the last participant is assessed for the primary endpoint, so it is the nearest public marker of a readout, not a confirmed date. Dates move: recent moves are on the delayed readouts page, and every phase is on the readout calendar.

Summary

202 studies (176 Phase 3, 26 Phase 2/3) across 164 drugs.

November 2026

Primary completionDrugDeveloperIndicationPhaseStudy
2026-11 (month only)TemozolomideMerck & Co.High-Risk Neuroblastoma, Patient With Insufficient Response ChemoimmunotherapyPhase 3NCT04221035
2026-11 (month only)vidofludimus calciumImmunic, Inc.Multiple SclerosisPhase 3NCT05134441
2026-11 (month only)vidofludimus calciumImmunic, Inc.Multiple SclerosisPhase 3NCT05201638
2026-11 (month only)ObicetrapibA. Menarini, NewAmsterdam Pharma, Tanabe Pharma CorporationAtherosclerotic Cardiovascular DiseasePhase 3NCT05202509
2026-11 (month only)TadalafilEli Lilly, Nippon Shinyaku, United TherapeuticsFontan PalliationPhase 3NCT05206955
2026-11 (month only)AbataceptBristol-Myers SquibbRheumatoid ArthritisPhase 3NCT05428488
2026-11 (month only)metforminSteinert's Disease, Myotonic Dystrophy 1, MetforminPhase 3NCT05532813
2026-11 (month only)Izalontamab brengitecan, Docetaxel, CapecitabineBristol-Myers Squibb, Sichuan Baili Pharmaceutical, SanofiNasopharyngeal CarcinomaPhase 3NCT06118333
2026-11 (month only)MethotrexateModerate to Severe Atopic DermatitisPhase 3NCT06239311
2026-11 (month only)CadonilimabAkesoGastric and Gastroesophageal Junction AdenocarcinomaPhase 3NCT06341335
2026-11 (month only)upadacitinib, dupilumabAbbVie, Regeneron Pharmaceuticals, SanofiAtopic DermatitisPhase 3NCT06389136
2026-11 (month only)Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT06448312
2026-11 (month only)retatrutideEli LillyObesityPhase 3NCT06662383
2026-11 (month only)Tislelizumab, pemetrexedBeOne Medicines, Eli LillyNon-Small Cell Lung CancerPhase 3NCT06704620
2026-11 (month only)Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT06914895
2026-11 (month only)Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT06962280
2026-11 (month only)ZemprocitinibLynk Pharmaceuticals, Simcere PharmaceuticalAnkylosing SpondylitisPhase 3NCT07237568
2026-11-24AvelumabMerck KGaASolid TumorsPhase 3NCT03815643
2026-11-24Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT06585787
2026-11-25Soficitinib (ICP-332)Beijing InnoCare Pharma Tech Co.Atopic DermatitisPhase 3NCT06775860
2026-11-25rilzabrutinibSanofiImmune ThrombocytopeniaPhase 3NCT07216079
2026-11-26Niraparib, DostarlimabGlaxoSmithKline, Zai LabEndometrial CancerPhase 3NCT03981796
2026-11-26MT1013Everest Medicines (Beijing) Co., Ltd., Shaanxi Micot Pharmaceutical TechnologyChronic Kidney Disease, Secondary HyperparathyroidismPhase 3NCT07122401
2026-11-29Rimegepant (Nurtec ODT)Eisai, PfizerMigrainePhase 3NCT06641466
2026-11-30Methotrexate, DexamethasoneAcute Lymphoblastic LeukemiaPhase 3NCT03020030
2026-11-30AtezolizumabChugai Pharma, RocheCancerPhase 3NCT03148418
2026-11-30Doravirine, DolutegravirMerck & Co., Shionogi, ViiV HealthcareHIVPhase 3NCT04892654
2026-11-30Ferric carboxymaltoseDaiichi Sankyo, Vifor PharmaAdvanced Gastric CarcinomaPhase 3NCT05226169
2026-11-30Nab-paclitaxel, SintilimabBristol-Myers Squibb, Innovent BiologicsNon-Small Cell Lung CancerPhase 3NCT05429463
2026-11-30EmpagliflozinBoehringer Ingelheim, Eli LillyEmpagliflozin in Cardiorenal Syndrome Type 1Phase 2/3NCT06030843
2026-11-30DapagliflozinAstraZeneca, Ono PharmaceuticalAtrial Fibrillation Recurrent, Catheter AblationPhase 2/3NCT06111443
2026-11-30GemcitabineEli LillyLocally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapyPhase 3NCT06156514
2026-11-30TaragarestrantInventisBioHR+/HER2- Metastatic Breast CancerPhase 3NCT06954961
2026-11-30WD-890Ningbo/Zhejiang Wenda Pharma Technology Co.PsoriasisPhase 3NCT07672561

December 2026

Primary completionDrugDeveloperIndicationPhaseStudy
2026-12 (month only)viloxazineKnight Therapeutics, M8 Pharmaceuticals, Supernus PharmaceuticalsAttention Deficit Hyperactivity DisorderPhase 3NCT02736656
2026-12 (month only)DocetaxelSanofiProstate CancerPhase 2/3NCT03258320
2026-12 (month only)MethotrexateCardiac Sarcoidosis, SarcoidosisPhase 3NCT03593759
2026-12 (month only)RalinepagUnited TherapeuticsPulmonary Arterial HypertensionPhase 3NCT03683186
2026-12 (month only)Cetuximab, Nivolumab, Binimetinib, Encorafenib, PertuzumabEli Lilly, Merck KGaA, Bristol-Myers SquibbMetastatic Colon Cancer, Stage III Colon CancerPhase 3NCT03803553
2026-12 (month only)PalbociclibPfizerHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT03820830
2026-12 (month only)Niraparib, Capivasertib, DocetaxelGlaxoSmithKline, Zai Lab, Astex Pharmaceuticals, Inc.Prostate Cancer, Metastatic Castration-Resistant Prostate CancerPhase 3NCT03903835
2026-12 (month only)DurvalumabAstraZenecaOropharyngeal CancerPhase 3NCT04116047
2026-12 (month only)Camrelizumab, ApatinibElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesGastric CancerPhase 2/3NCT04208347
2026-12 (month only)apremilastAmgenRecurrent Aphtous StomatitisPhase 3NCT04227314
2026-12 (month only)PenpulimabAkeso, Chia Tai Tianqing Pharmaceutical GroupHepatocellular CarcinomaPhase 3NCT04344158
2026-12 (month only)Selinexor, Rituximab, DexamethasoneA. Menarini, Antengene Corporation Limited, FORUS Therapeutics Inc.Diffuse Large B-Cell LymphomaPhase 2/3NCT04442022
2026-12 (month only)Durvalumab, Tremelimumab, pemetrexedAstraZeneca, MedImmune LLC, Eli LillyNon-Small Cell Lung CancerPhase 3NCT04585490
2026-12 (month only)Sacituzumab GovitecanGilead SciencesHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT04639986
2026-12 (month only)Surabgene lomparvovecAbbVie, REGENXBIO Inc.Age-Related Macular DegenerationPhase 2/3NCT04704921
2026-12 (month only)FurmonertinibAllist Pharmaceuticals, ArriVent BioPharmaNon-small Cell Lung CarcinomaPhase 3NCT04853342
2026-12 (month only)Rinvecalinase alfaDiaMedica TherapeuticsAcute Ischemic StrokePhase 2/3NCT05065216
2026-12 (month only)Bevacizumab, Olvimulogene nanivacirepvecRoche, Genelux Corporation, Newsoara HYK Biopharmaceuticals Co., Ltd.Ovarian CancerPhase 3NCT05281471
2026-12 (month only)ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceNasopharyngeal CarcinomaPhase 3NCT05340491
2026-12 (month only)DonidalorsenIonis Pharmaceuticals, Otsuka Holdings, TheratechnologiesHereditary AngioedemaPhase 3NCT05392114
2026-12 (month only)MasupirdineSuven Life SciencesAlzheimer's DiseasePhase 3NCT05397639
2026-12 (month only)CanagliflozinDaiichi Sankyo, Johnson & Johnson, Tanabe Pharma CorporationType 2 DiabetesPhase 2/3NCT05427084
2026-12 (month only)Actinium (225Ac) oxodotreotideBristol-Myers SquibbGEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NETPhase 3NCT05477576
2026-12 (month only)ResmetiromMadrigal PharmaceuticalsMASH / NASHPhase 3NCT05500222
2026-12 (month only)BevacizumabRocheNon-Small Cell Lung CancerPhase 3NCT05654454
2026-12 (month only)PegtarazimodReAlta Life SciencesHypoxic-Ischemic EncephalopathyPhase 2/3NCT05778188
2026-12 (month only)Tamoxifen (Soltamox), Anastrozole, Letrozole, CulmerciclibMayne Pharma, Rosemont Pharmaceuticals, ANI Pharmaceuticals, Inc.Breast CancerPhase 3NCT05780567
2026-12 (month only)SintilimabInnovent BiologicsGastric CancerPhase 3NCT05918094
2026-12 (month only)TinengotinibTransThera Sciences (Nanjing), Inc.CholangiocarcinomaPhase 3NCT05948475
2026-12 (month only)OpakalimBiohavenEpilepsy, Focal Onset SeizuresPhase 2/3NCT06132893
2026-12 (month only)TislelizumabBeOne MedicinesNasopharyngeal CarcinomaPhase 3NCT06177301
2026-12 (month only)Cadonilimab, Disitamab VedotinAkeso, Pfizer, RemeGen Co., Ltd.Gastric CancerPhase 2/3NCT06221748
2026-12 (month only)SeralutinibGossamer BioPulmonary Arterial HypertensionPhase 3NCT06274801
2026-12 (month only)Izalontamab brengitecan, DocetaxelBristol-Myers Squibb, Sichuan Baili Pharmaceutical, SanofiNon-Small Cell Lung CancerPhase 3NCT06382129
2026-12 (month only)SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Binge-Eating DisorderPhase 3NCT06413433
2026-12 (month only)lutikizumabAbbVieHidradenitis SuppurativaPhase 3NCT06468228
2026-12 (month only)LumateperoneIntra-Cellular Therapies, Johnson & JohnsonSchizophreniaPhase 3NCT06482554
2026-12 (month only)Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalSmall Cell Lung CancerPhase 3NCT06500026
2026-12 (month only)SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Excessive Sleepiness, Shift-work DisorderPhase 3NCT06568367
2026-12 (month only)Ruzaltatug rezetecanJiangsu Hengrui PharmaceuticalsNon-Small Cell Lung CancerPhase 3NCT06671379
2026-12 (month only)Pembrolizumab, Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT06711900
2026-12 (month only)CrofelemerFuture Pak, LLC, Jaguar Health, Napo PharmaceuticalsMicrovillus Inclusion Disease, Congenital Disorders, Rare DiseasesPhase 2/3NCT06721871
2026-12 (month only)DolutegravirShionogi, ViiV HealthcareHIVPhase 3NCT06747507
2026-12 (month only)pemetrexedEli LillyNon-Small Cell Lung CancerPhase 3NCT06754644
2026-12 (month only)IvonescimabAkeso, Summit TherapeuticsTriple-Negative Breast Cancer (TNBC)Phase 3NCT06767527
2026-12 (month only)upadacitinib, Pirfenidone (Esbriet)AbbVie, Legacy Pharma Inc. SEZC, RocheLong COVIDPhase 3NCT06928272
2026-12 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT06974851
2026-12 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT06994650
2026-12 (month only)RelutriginePraxis Precision Medicines, Inc.Epilepsy, Developmental and Epileptic EncephalopathiesPhase 3NCT07010471
2026-12 (month only)ElsunersenIonis Pharmaceuticals, Praxis Precision Medicines, Inc.EpilepsyPhase 3NCT07019922
2026-12 (month only)Semaglutide (Ozempic)Novo NordiskType 2 DiabetesPhase 3NCT07059377
2026-12 (month only)metformin, Alogliptin, EmpagliflozinTakeda Pharmaceutical Company, Teijin, Boehringer IngelheimType 2 DiabetesPhase 3NCT07093476
2026-12 (month only)Tobevibart (VIR-3434)Brii Biosciences, Norgine, Vir BiotechnologyChronic Hepatitis DeltaPhase 3NCT07128550
2026-12 (month only)difamilastAcrotech Biopharma, Otsuka HoldingsAtopic DermatitisPhase 3NCT07173478
2026-12 (month only)stapokibartAeira Pte. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Keymed BiosciencesSeasonal Allergic Rhinitis (SAR)Phase 3NCT07678931
2026-12 (month only)SHR-1819Jiangsu Hengrui PharmaceuticalsSeasonal Allergic RhinitisPhase 3NCT07688772
2026-12-01Pyrotinib, EpirubicinDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 2/3NCT04290793
2026-12-01SPH4336Shanghai Pharmaceuticals HoldingHR+/HER2- Metastatic Breast CancerPhase 2/3NCT05860465
2026-12-01TislelizumabBeOne MedicinesLocally Advanced Rectal CarcinomaPhase 2/3NCT06312982
2026-12-01FelzartamabBiogenAntibody-mediated RejectionPhase 3NCT06685757
2026-12-01MaravirocViiV HealthcareLong COVIDPhase 2/3NCT06974084
2026-12-01Cetuximab, PembrolizumabEli Lilly, Merck KGaA, Merck & Co.Head and Neck Squamous Cell CarcinomaPhase 3NCT06998069
2026-12-01RAY1225Guangdong Raynovent Biotech, Qilu PharmaceuticalType 2 DiabetesPhase 3NCT07139535
2026-12-01RAY1225Guangdong Raynovent Biotech, Qilu PharmaceuticalType 2 DiabetesPhase 3NCT07139548
2026-12-01tradipitantVanda PharmaceuticalsNausea and Vomiting, ObesityPhase 3NCT07446439
2026-12-01VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 3NCT07712848
2026-12-02PF-06651600PfizerSevere Alopecia AreataPhase 3NCT07029711
2026-12-04AnakinraSwedish Orphan Biovitrum AB (publ)FMFPhase 3NCT06336733
2026-12-04PF-07307405PfizerLyme DiseasePhase 3NCT07500506
2026-12-06DexamethasoneNausea and Vomiting Caused by ChemotherapyPhase 3NCT07716176
2026-12-06DexamethasoneNausea and Vomiting Caused by Trastuzumab DeruxtecanPhase 3NCT07716189
2026-12-06DexamethasoneNausea and Vomiting Caused by ChemotherapyPhase 3NCT07716228
2026-12-07EculizumabAlexion Pharmaceuticals, Inc. (subsidiary of AstraZeneca)NMOSD, Neuromyelitis Optica Spectrum DisordersPhase 3NCT06724809
2026-12-08MilvexianBristol-Myers Squibb, Johnson & JohnsonAtrial FibrillationPhase 3NCT05757869
2026-12-09Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT06126224
2026-12-10ZongertinibBoehringer IngelheimNon-Small Cell Lung CancerPhase 3NCT06151574
2026-12-12Osimertinib, CPO301AstraZeneca, Conjupro Biotherapeutics, Inc.Non-Small Cell Lung CancerPhase 3NCT07376382
2026-12-13ivarmacitinibJiangsu Hengrui Pharmaceuticals, Reistone BiopharmaPsoriatic ArthritisPhase 3NCT04957550
2026-12-13crisaborolePfizerPsoriasis, Psoriasis GenitalPhase 3NCT07892339
2026-12-14Abp 234AmgenNon-Small Cell Lung CancerPhase 3NCT06430866
2026-12-15Atezolizumab, PertuzumabChugai Pharma, RocheBreast CancerPhase 3NCT03595592
2026-12-15Cariprazine (Vraylar)AbbVie, Gedeon Richter, Tanabe Pharma CorporationSchizophreniaPhase 3NCT03817502
2026-12-15Nivolumab, ZanzalintinibBristol-Myers Squibb, Ono Pharmaceutical, ExelixisRenal Cell CarcinomaPhase 3NCT05678673
2026-12-15N-acetylcysteineApotex Inc., Phebra Pty LtdPsychosisPhase 3NCT05796401
2026-12-15DexamethasoneHospital Acquired PneumoniaPhase 3NCT06269900
2026-12-15GefurulimabAstraZenecaGeneralized Myasthenia GravisPhase 3NCT06607627
2026-12-15TemozolomideMerck & Co.Neuroblastoma (NB), GanglioneuroblastomaPhase 3NCT07375563
2026-12-16Docetaxel (HB1801)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.HER2-Positive Breast CancerPhase 3NCT06747338
2026-12-17ElafibranorGenfit, IpsenPrimary Biliary CholangitisPhase 3NCT06730061
2026-12-17OveporextonTakeda Pharmaceutical CompanyNarcolepsyPhase 3NCT07363720
2026-12-20DexamethasoneFacial Injuries, Pain, SwellingPhase 2/3NCT07853664
2026-12-21bimekizumabUCBHidradenitis SuppurativaPhase 3NCT06921850
2026-12-22Ixoberogene soroparvovecEli LillyWet Age-Related Macular DegenerationPhase 3NCT06856577
2026-12-22SuzetrigineVertex PharmaceuticalsBariatric Surgery, Cardiac Surgery With Sternotomy, Post-operative PainPhase 3NCT07539623
2026-12-23BenralizumabAstraZeneca, Kyowa Kirin, MedImmune LLCAsthmaPhase 3NCT05692180
2026-12-24VemurafenibRocheColorectal Cancer MetastaticPhase 3NCT06008119
2026-12-26TrelagliptinTakeda Pharmaceutical Company, TeijinType 2 DiabetesPhase 3NCT07073768
2026-12-28Carfilzomib, Bortezomib, Lenalidomide, DexamethasoneAmgen, Ono Pharmaceutical, JanssenMultiple MyelomaPhase 3NCT03729804
2026-12-28TH-SC01Jiangsu Topcel-KH PharmaceuticalCrohn's DiseasePhase 3NCT06925594
2026-12-28Olanzapine (Zyprexa)Cheplapharm Arzneimittel GmbH, Eli LillyOncology Patients Receiving Chemotherapy, Cachexia-Anorexia Syndrome, OncologyPhase 3NCT07633236
2026-12-30CetrelimabJohnson & JohnsonBladder CancerPhase 3NCT04658862
2026-12-30ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceNon-Small Cell Lung CancerPhase 3NCT04772287
2026-12-30Camrelizumab, ApatinibElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesHepatocellular CarcinomaPhase 2/3NCT05062837
2026-12-30Sintilimab, Bevacizumab, CapecitabineInnovent Biologics, Roche, Cheplapharm Arzneimittel GmbHColorectal Cancer, Metastatic Colorectal CancerPhase 3NCT05171660
2026-12-30Palbociclib, VepdegestrantPfizer, Arvinas Inc., Rigel PharmaceuticalsHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT05909397
2026-12-30TAK-921Takeda Pharmaceutical CompanyUnresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 3NCT06238843
2026-12-30SeltorexantJohnson & JohnsonMajor Depressive DisorderPhase 3NCT06559306
2026-12-30SumecigrelEverest Medicines (Beijing) Co., Ltd., Jiangsu Vcare Pharmaceutical Technology Co., Ltd.Atherosclerotic Cardiovascular DiseasePhase 3NCT06577519
2026-12-30Sodium zirconium cyclosilicateAstraZenecaChronic Kidney DiseasePhase 3NCT06578078
2026-12-30Anbenitamab repodatecanAlphamab Oncology, CSPC Pharmaceutical GroupOvarian Cancer, Primary Peritoneal, Fallopian Tube CancersPhase 3NCT06751485
2026-12-30Descartes-08Cartesian Therapeutics, Inc.Myasthenia GravisPhase 3NCT06799247
2026-12-30VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 2/3NCT07264010
2026-12-30TelitaciceptRemeGen Co., Ltd., Vor BioInflammatory MyopathyPhase 2/3NCT07355257
2026-12-30Pirfenidone (Esbriet)Legacy Pharma Inc. SEZC, RocheRadiation-induced Lung Injury, Immune-related PneumoniaPhase 2/3NCT07388680
2026-12-31TemozolomideMerck & Co.GliomaPhase 3NCT00978458
2026-12-31IbrutinibAbbVie, Johnson & JohnsonDiffuse Large B-Cell Lymphoma, Graft-versus-Host Disease, Chronic Graft-versus-Host Disease, Mantle Cell Lymphoma, Chronic Lymphocytic LeukemiaPhase 3NCT01804686
2026-12-31Carfilzomib, Bortezomib, Lenalidomide, DexamethasoneAmgen, Ono Pharmaceutical, JanssenMultiple MyelomaPhase 3NCT01863550
2026-12-31GemcitabineEli LillyHepatoblastoma, Carcinoma, HepatocellularPhase 3NCT03017326
2026-12-31BevacizumabRocheColorectal CancerPhase 3NCT03303495
2026-12-31PembrolizumabMerck & Co.Merkel Cell CarcinomaPhase 3NCT03712605
2026-12-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceHepatocellular CarcinomaPhase 2/3NCT03859128
2026-12-31LecanemabBiogen, EisaiAlzheimer's DiseasePhase 3NCT03887455
2026-12-31MigalastatAmicus Therapeutics, BioMarin PharmaceuticalFabry DiseasePhase 3NCT04020055
2026-12-31PembrolizumabMerck & Co.Lung CancerPhase 2/3NCT04093167
2026-12-31Tislelizumab, zanubrutinibBeOne MedicinesB-cell MalignanciesPhase 3NCT04170283
2026-12-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceAdvanced Hepatocellular Carcinoma (HCC)Phase 3NCT04523493
2026-12-31DexamethasoneHodgkin Lymphoma, AdultPhase 3NCT04638790
2026-12-31FluzoparibJiangsu Hengrui PharmaceuticalsMetastatic Castration-Resistant Prostate CancerPhase 3NCT04691804
2026-12-31AlmonertinibGlenmark Pharmaceuticals Ltd., Hansoh Pharmaceutical GroupNon-Small Cell Lung CancerPhase 3NCT04841811
2026-12-31MethylprednisolonePfizerOpioid Use, Lumbar Spinal Stenosis, Pain, Postoperative, Pain, BackPhase 3NCT05058287
2026-12-31Lorlatinib, Avelumab, Axitinib, pemetrexed, TalazoparibPfizer, Merck KGaA, Eli LillyNon-Small Cell Lung Cancer, Urothelial CarcinomaPhase 3NCT05059522
2026-12-31Toripalimab, Disitamab VedotinCoherus BioSciences, Inc., Shanghai Junshi Bioscience, PfizerUrothelial CarcinomaPhase 3NCT05302284
2026-12-31DurvalumabAstraZenecaCancerPhase 3NCT05303532
2026-12-31EmpagliflozinBoehringer Ingelheim, Eli LillyHeart FailurePhase 3NCT05392764
2026-12-31Trastuzumab rezetecanGlenmark Pharmaceuticals Ltd., Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT05424835
2026-12-31MethotrexateT-cell Lymphoblastic LymphomaPhase 3NCT05681260
2026-12-31GemcitabineEli LillyCervical Cancer, Cervix Cancer, Cervix NeoplasmPhase 3NCT05764044
2026-12-31S-1, DocetaxelNordic Group B.V., Taiho Pharmaceutical, SanofiLocally Advanced Gastric Adenocarcinoma, Chemotherapy EffectPhase 3NCT05813015
2026-12-31TislelizumabBeOne MedicinesAdvanced CholangiocarcinomaPhase 3NCT05823311
2026-12-31Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06081959
2026-12-31LisaftoclaxAscentage Pharma Group Inc.CLL/SLLPhase 3NCT06104566
2026-12-31CetuximabEli Lilly, Merck KGaAMetastatic Colorectal CancerPhase 3NCT06226857
2026-12-31ChidamideChipscreen Biosciences, GNT Biotech & Medicals, HUYABIO International, LLC.Extranodal Natural Killer T Cell LymphomaPhase 3NCT06255795
2026-12-31Bevacizumab, SerplulimabRoche, Abbott, Accord HealthcareColorectal CancerPhase 2/3NCT06280495
2026-12-31DapagliflozinAstraZeneca, Ono PharmaceuticalHeart FailurePhase 3NCT06304857
2026-12-31Nab-paclitaxel, TemozolomideBristol-Myers Squibb, Merck & Co.GliomaPhase 3NCT06330337
2026-12-31AzacitidineBristol-Myers SquibbAcute Myeloid LeukemiaPhase 3NCT06345365
2026-12-31RademikibartConnect Biopharma, Simcere PharmaceuticalAsthmaPhase 3NCT06488755
2026-12-31VicadrostatBoehringer IngelheimChronic Kidney DiseasePhase 3NCT06531824
2026-12-31Camrelizumab, CapecitabineElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Cheplapharm Arzneimittel GmbHTriple-negative Breast CancerPhase 3NCT06533384
2026-12-31BexicaserinH. LundbeckEpilepsyPhase 3NCT06660394
2026-12-31FurmonertinibAllist Pharmaceuticals, ArriVent BioPharmaNon-Small Cell Lung CancerPhase 3NCT06674343
2026-12-31Icosapent EthylAmarin Corporation, RecordatiInflammation, Community Acquired Pneumonia (CAP), Inflammation Plaque, AtheroscleroticPhase 3NCT06710080
2026-12-31SC0062BioCity BiopharmaceuticsChronic Kidney DiseasePhase 3NCT06819826
2026-12-31mazdutideEli Lilly, Innovent BiologicsObesityPhase 3NCT06884293
2026-12-31DapagliflozinAstraZeneca, Ono PharmaceuticalPediatric Hereditary Kidney DiseasesPhase 3NCT06890143
2026-12-31PembrolizumabMerck & Co.Esophageal Squamous Cell CarcinomaPhase 2/3NCT06907602
2026-12-31TislelizumabBeOne MedicinesGastric CancerPhase 3NCT06939439
2026-12-31VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 3NCT06990321
2026-12-31upadacitinibAbbVieCrohn's DiseasePhase 3NCT07149467
2026-12-31PembrolizumabMerck & Co.Non-Small Cell Lung CancerPhase 3NCT07162883
2026-12-31TelitaciceptRemeGen Co., Ltd., Vor BioMyasthenia Gravis, OcularPhase 3NCT07249632
2026-12-31N-acetylcysteineApotex Inc., Phebra Pty LtdThrombotic MicroangiopathyPhase 2/3NCT07279610
2026-12-31AzvudineHenan Genuine BiotechChronic Hepatitis B, AzvudinePhase 3NCT07307586
2026-12-31EculizumabAlexion Pharmaceuticals, Inc. (subsidiary of AstraZeneca)Neuromyelitis Optica Spectrum Disorders (NMOSD)Phase 3NCT07420296
2026-12-31Venetoclax, AzacitidineAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 3NCT07486479
2026-12-31HRS-9190Jiangsu Hengrui PharmaceuticalsAdult Participants Requiring Tracheal Intubation Under General Anesthesia for Elective SurgeryPhase 3NCT07733245
2026-12-31HRS-9190Jiangsu Hengrui PharmaceuticalsNeuromuscular BlockadePhase 3NCT07746726

Source: ClinicalTrials.gov, each study's record, checked daily. Studies that are terminated, withdrawn or completed are left out, as are programmes their developer has stopped. A month-only date is shown as given.